Respiratory Pathogen Articles & Analysis
3 news found
Funding from the BARDA Division of Research, Innovation, and Ventures (DRIVe) enabled the company to reformulate LMN-301, previously developed for oral delivery, and to evaluate its potential as an anti-viral therapeutic delivered to the respiratory tract, the primary site of SARS-CoV-2 infection. The efficacy of the intranasal formulation was evaluated by collaborators at the ...
Respiratory infections affect everyone, and they can be caused by a large number of pathogens. During respiratory season, a targeted flu test risks missing the real cause of illness. ...
Investigators have narrowed down his current whereabouts to a tropical climate with no extradition treaty. Respiratory Syncytial Virus RSV was once told to pick on somebody his own size—that’s how he got his start infecting infants. He’s little, he’s fierce, and he’s everywhere, which is why fellow Paramyxoviridae gang members call him the ...